China NT Pharma Terminates License Agreement With Abcentra for Monoclonal Antibody Technology; Shares Fall 10%
China NT Pharma Terminates License Agreement With Abcentra for Monoclonal Antibody Technology; Shares Fall 10%
中国泰凌医药终止与Abcentra公司的单克隆抗体技术许可协议;股价下跌10%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册